Rheumatoid Arthritis Clinical Trials in Dallas, Texas

5 studies are recruiting for rheumatoid arthritis in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

2. A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

   This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Nkarta Investigational Site, Dallas, Texas

   Locations

   18 in total

   Run by

   Nkarta, Inc.

   See if you can join NCT06733935 on ClinicalTrials.gov

3. RA-PRO PRAGMATIC TRIAL

   The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Southwest Medical Center, Dallas, Texas

   Locations

   49 in total

   Run by

   University of Alabama at Birmingham

   See if you can join NCT04692493 on ClinicalTrials.gov

4. Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis

   This two-stage, multicenter clinical trial is designed to evaluate the feasibility, safety, and preliminary efficacy of splenic ultrasound stimulation to activate immune-neuromodulation (SUSTAIN) in patients with rheumatoid arthritis (RA) and at least moderate disease activity. The findings from th…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Rheumatology Associates, Dallas, Texas

   Locations

   3 in total

   Run by

   Surf Therapeutics

   See if you can join NCT07293871 on ClinicalTrials.gov

5. ConsideRAte Study - Splenic Stimulation for RA

   This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable pulse generator, external components and accessories. The study will consist of 4 study periods, including a Randomized…

   Stage

   Not phased

   Ages

   22 to 75

   Site

   Metroplex Clinical Research Center, Dallas, Texas

   Locations

   14 in total

   Run by

   Galvani Bioelectronics

   See if you can join NCT05003310 on ClinicalTrials.gov